Results 181 to 190 of about 28,321 (229)
Some of the next articles are maybe not open access.

The Hypercoagulability of Polycythemia Vera

Hospital Practice, 1993
Thrombosis is the most common cause of death in patients with this myeloproliferative syndrome. Phlebotomy, hydroxyurea, and antiplatelet agents are the mainstays of therapy but may not stave off a lethal embolism.
W, Fields, N J, Freeman
openaire   +2 more sources

Polycythemia Vera: A Review

Clinical Journal of Oncology Nursing, 2003
Polycythemia vera (PV) is a clonal stem cell disorder characterized by increased erythrocyte production. Its etiology is not fully understood, and hemorrhage, thrombosis, and hyperviscosity may occur at any time during the course of this disorder. Treatment depends on the most affected cell type, duration and severity of the condition, and patient age.
openaire   +2 more sources

Anesthesia for polycythemia vera

Journal of Clinical Anesthesia, 1990
Cystoscopy was postponed on an 80-year-old male found to have a hematocrit of 57%. After the diagnosis of polycythemia vera was made, he was phlebotomized and treated with hydroxyurea. He was readmitted 2 months later for transurethral resection of the prostate. After the induction of general endotracheal anesthesia with thiopental and succinylcholine,
openaire   +2 more sources

Polycythemia Vera in Dogs

Journal of the American Veterinary Medical Association, 1974
SUMMARY The historical and laboratory findings in 5 published reports and 3 additional cases of polycythemia vera in the dog were reviewed. The consistent abnormal findings included increased packed cell volume (pcv), hemoglobin concentration, red blood cell (rbc) count, rbc mass, and total blood volume.
openaire   +2 more sources

POLYCYTHEMIA VERA IN CHILDHOOD

Archives of Pediatrics & Adolescent Medicine, 1972
To the Editor.—The recent communication by Natelson et al1at the first glance appears to add another report to the compendium of chromosomal abnormalities, specific or nonspecific, as the case may be. The nonspecific chromosomal abnormalities probably are not significant since they may not have any relation to the clinical nature or etiology of the ...
openaire   +2 more sources

Treatment of Polycythemia Vera

Seminars in Thrombosis and Hemostasis, 2006
The selection of treatment for patients with polycythemia vera (PV) still is the subject of much discussion among hematologists. It is emphasized that important physiologic and pathogenic components of the illness relate not only to the erythroid cell, but also to the megakaryocyte.
openaire   +2 more sources

Polycythemia vera and other primary polycythemias

Current Opinion in Hematology, 2005
Diagnosis and therapy of polycythemia vera are controversial since the molecular basis of polycythemia vera remains unknown. Distinguishing between polycythemia vera and other polycythemic disorders can be very challenging. The purpose of this review is to discuss the recent progress in this area and critically review the published data in context of ...
openaire   +2 more sources

Polycythemia Vera

Medical Clinics of North America, 1956
C F, STROEBEL, W M, LAW
openaire   +3 more sources

Polycythemia Vera

The Guthrie Journal, 1954
S D, CONKLIN, J H, SHINDEL
openaire   +2 more sources

POLYCYTHEMIA VERA

Journal of the American Medical Association, 1944
This is a final report on a case of polycythemia vera which was under observation for seventeen years, and for eleven of these years under continual treatment with phenylhydrazine hydrochloride. It is presented (1) because of the long period of treatment with the drug, (2) to record the changed blood picture during the last six years of life and (3) to
openaire   +1 more source

Home - About - Disclaimer - Privacy